A limited sampling model for the pharmacokinetics of etoposide given orally

Donatella Gentili, Massimo Zucchetti, Valter Torri, Cristiana Sessa, Jolanda de Jong, Franco Cavalli, Maurizio D'Incalci

Research output: Contribution to journalArticlepeer-review

Abstract

A limited sampling model of etoposide after oral administration to estimate the area under the plasma concentration-time curve from 0 to 24 h (AUC) by determination of the drug plasma levels at only two time points was developed by a multiple regression analysis on a training data set of 15 patients receiving oral doses ranging from 54 to 90 mg/m2. The equation describing the model is AUC (μg ml-1 h)=5.183 (μg ml-1 h)+1.193 (h)×C1h (μg/ml)+8.439 (h)×C4h (μg/ml) (R2=0.93, P=0.0001), where C1h and C4h represent the plasma etoposide concentrations at 1 and 4 h, respectively. The model was validated prospectively on a test data set of 13 patients receiving oral doses ranging from 52 to 87 mg/m2 and, additionally, on a data set of 7 patients receiving oral doses ranging between 176 and 200 mg/m2, investigated in a previous study. Validation on both test data sets gave a relative mean predictive error of 0.1% and a relative root mean square error of 15.8% and 16.7%, respectively. The present study shows that it is possible to obtain a good estimate of the plasma AUC after oral administration of etoposide using a two-time-point sampling model. The model can be used to monitor the etoposide AUC in patients receiving chronic oral treatment.

Original languageEnglish
Pages (from-to)482-486
Number of pages5
JournalCancer Chemotherapy and Pharmacology
Volume32
Issue number6
DOIs
Publication statusPublished - Nov 1993

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'A limited sampling model for the pharmacokinetics of etoposide given orally'. Together they form a unique fingerprint.

Cite this